{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:45:52Z","timestamp":1787021152295,"version":"build-2736575974"},"reference-count":42,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"name":"Indonesia Endowment for Education"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,9,6]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As a vulnerable population, children and adolescents with tuberculosis (TB) are faced with many challenges, even those who live in low TB incidence countries. We aimed to evaluate factors associated with TB treatment outcomes allowing more focused interventions to support this population once diagnosed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study using a nationwide surveillance database was performed in children and adolescents (aged 0\u201318\u2005years) treated for TB in the Netherlands from 1993 to 2018. Logistic regression analyses were used to estimate adjusted odds ratios (aOR) for associated factors of mortality and loss to follow-up (LTFU).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 3253 eligible patients with known outcomes, 94.4% (95.9% children and 92.8% adolescents) were cured or completed treatment, 0.7% died during treatment and 4.9% were LTFU. There were no reported treatment failures. Risk factors of death included children aged 2\u20134\u2005years (aOR 10.42), central nervous system TB (aOR 5.14), miliary TB (aOR 10.25), HIV co-infection (aOR 8.60), re-treated TB cases (aOR 10.12) and drug-induced liver injury (aOR 6.50). Active case-finding was a protective factor of death (aOR 0.13). Risk factors of LTFU were adolescents aged 15\u201318\u2005years (aOR 1.91), illegal immigrants (aOR 4.28), urban domicile (aOR 1.59), unknown history of TB contact (aOR 1.99), drug-resistant TB (aOR 2.31), single adverse drug reaction (aOR 2.12), multiple adverse drug reactions (aOR 7.84) and treatment interruption &gt;14\u2005days (aOR 6.93). Treatment in recent years (aOR 0.94) and supervision by public health nurses (aOR 0.14) were protective factors of LTFU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Highly successful treatment outcomes were demonstrated in children and adolescents routinely treated for TB. Special attention should be given to specific risk groups to improve treatment outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.01402-2019","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T12:25:24Z","timestamp":1568291124000},"page":"1901402","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands"],"prefix":"10.1183","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-9018","authenticated-orcid":false,"given":"Fajri","family":"Gafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"van't Boveneind-Vrubleuskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"2024102101103197000_54.6.1901402.1","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2018. Geneva, WHO, 2018. www.who.int\/tb\/publications\/global_report\/en\/ Date last accessed: July 9, 2019."},{"key":"2024102101103197000_54.6.1901402.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02352-2017"},{"key":"2024102101103197000_54.6.1901402.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00176-2018"},{"key":"2024102101103197000_54.6.1901402.4","unstructured":"World Health Organization (WHO). Roadmap for childhood tuberculosis. Geneva, WHO, 2013. www.who.int\/tb\/areas-of-work\/children\/roadmap\/en\/"},{"key":"2024102101103197000_54.6.1901402.5","unstructured":"World Health Organization (WHO). Roadmap towards ending TB in children and adolescents, second edition. Geneva, WHO, 2018. www.who.int\/tb\/publications\/2018\/tb-childhoodroadmap\/en\/ Date last accessed: July 9, 2019."},{"key":"2024102101103197000_54.6.1901402.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30474-1"},{"key":"2024102101103197000_54.6.1901402.7","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30289-9"},{"key":"2024102101103197000_54.6.1901402.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014"},{"key":"2024102101103197000_54.6.1901402.9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0106-2018"},{"key":"2024102101103197000_54.6.1901402.10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix602"},{"key":"2024102101103197000_54.6.1901402.11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jpeds.2018.05.017","article-title":"Epidemiology of pediatric tuberculosis in Kenya and risk factors for mortality during treatment: a national retrospective cohort study","volume":"201","author":"Onyango","year":"2018","journal-title":"J Pediatr"},{"key":"2024102101103197000_54.6.1901402.12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.5588\/ijtld.13.0238","article-title":"Towards the WHO target of zero childhood tuberculosis deaths: an analysis of mortality in 13 locations in Africa and Asia","volume":"17","author":"Russell","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102101103197000_54.6.1901402.13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-61"},{"key":"2024102101103197000_54.6.1901402.14","first-page":"424","article-title":"Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes","volume":"6","author":"Harries","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102101103197000_54.6.1901402.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00704-2016"},{"key":"2024102101103197000_54.6.1901402.16","unstructured":"National Institute for Public Health and the Environment (RIVM). Osiris-NTR Tuberculose ziekte: Vragenlijst en handleiding 2017 [Osiris-NTR Tuberculosis Disease: Questionnaire and Manual 2017]. www.rivm.nl\/documenten\/osiris-ntr-ziekte-vragenlijst-2017 Date last accessed: July 9, 2019."},{"key":"2024102101103197000_54.6.1901402.17","unstructured":"Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (NVALT). Richtlijn Medicamenteuze Behandeling van Tuberculose [Guideline on medicinal treatment of tuberculosis]. 2014. www.kncvtbc.org\/uploaded\/2015\/09\/3.4_tuberculose.pdf Date last accessed: July 9, 2019."},{"key":"2024102101103197000_54.6.1901402.18","unstructured":"World Health Organization (WHO). Definitions and Reporting Framework for Tuberculosis \u2013 2013 Revision. Geneva, WHO, 2013. www.who.int\/tb\/publications\/definitions\/en\/ Date last accessed: August 14, 2019."},{"key":"2024102101103197000_54.6.1901402.19","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.139543"},{"key":"2024102101103197000_54.6.1901402.20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/mja15.00717","article-title":"The epidemiology of tuberculosis in children in Australia, 2003\u20132012","volume":"203","author":"Teo","year":"2015","journal-title":"Med J Aust"},{"key":"2024102101103197000_54.6.1901402.21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017855"},{"key":"2024102101103197000_54.6.1901402.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68507-3"},{"key":"2024102101103197000_54.6.1901402.23","unstructured":"de Vries G , Riesmeijer R . National Tuberculosis Control Plan 2016\u20132020: towards elimination. Bilthoven, National Institute for Public Health and the Environment, 2016. www.rivm.nl\/bibliotheek\/rapporten\/2016-0012.pdf Date last accessed: August 14, 2019."},{"key":"2024102101103197000_54.6.1901402.24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-295"},{"key":"2024102101103197000_54.6.1901402.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411602"},{"key":"2024102101103197000_54.6.1901402.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200206-626OC"},{"key":"2024102101103197000_54.6.1901402.27","doi-asserted-by":"crossref","first-page":"e0166030","DOI":"10.1371\/journal.pone.0166030","article-title":"Predictors of prolonged TB treatment in a Dutch outpatient setting","volume":"11","author":"van't Boveneind-Vrubleuskaya","year":"2016","journal-title":"PLoS One"},{"key":"2024102101103197000_54.6.1901402.28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/INF.0000000000002192","article-title":"Antituberculosis drug-induced liver injury in children: incidence and risk factors during the two-month intensive phase of therapy","volume":"38","author":"Gafar","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2024102101103197000_54.6.1901402.29","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.126175"},{"key":"2024102101103197000_54.6.1901402.30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12879-017-2330-z","article-title":"Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK","volume":"17","author":"Abbara","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2024102101103197000_54.6.1901402.31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1746.2012.07279.x","article-title":"Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury","volume":"28","author":"Devarbhavi","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2024102101103197000_54.6.1901402.32","unstructured":"World Health Organization (WHO). Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children (2nd ed). Geneva, WHO, 2014. www.who.int\/tb\/publications\/childtb_guidelines\/en\/ Date last accessed: July 9, 2019."},{"key":"2024102101103197000_54.6.1901402.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021836"},{"key":"2024102101103197000_54.6.1901402.34","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00579-2019"},{"key":"2024102101103197000_54.6.1901402.35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1700209","article-title":"Household-contact investigation for detection of tuberculosis in Vietnam","volume":"378","author":"Fox","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102101103197000_54.6.1901402.36","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2214-109X(18)30520-5","article-title":"Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial","volume":"7","author":"Lung","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024102101103197000_54.6.1901402.37","doi-asserted-by":"crossref","first-page":"e1329","DOI":"10.1016\/S2214-109X(18)30401-7","article-title":"Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study","volume":"6","author":"Dodd","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2024102101103197000_54.6.1901402.38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/pch\/13.1.19","article-title":"Adherence to treatment in adolescents","volume":"13","author":"Taddeo","year":"2008","journal-title":"Paediatr Child Health"},{"key":"2024102101103197000_54.6.1901402.39","first-page":"CD003343","article-title":"Directly observed therapy for treating tuberculosis","volume":"29","author":"Karumbi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102101103197000_54.6.1901402.40","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"key":"2024102101103197000_54.6.1901402.41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00424-2016"},{"key":"2024102101103197000_54.6.1901402.42","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806007540"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01402-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:23:48Z","timestamp":1740381828000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01402-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,12]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1183\/13993003.01402-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01402-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]}}}